Global Neurological Disorder Diagnostics Market, by Technology (Imaging and In Vitro Diagnostics), by Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), by End User (Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 10,774.6 Mn in 2017, and is projected to exhibit a CAGR of 7.3% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights. According to the Coherent Market Insights analysis global neurological disorder diagnostics market is expected to show a significant growth in the near future owing to frequent launches of novel diagnostic products in the market by key players.
For instance, in 2017, Koninklijke Philips N.V. launched its latest MR Prodiva 1.5T, a magnetic resonance imaging (MRI), which provides enhanced clinical performance, workflow, and patient experience. Furthermore, in March 2018, Koninklijke Philips N.V. also launched a new 3-tesla MRI scanner, Elition 3.0T, which reduces scanning time by 50%. Furthermore, in 2017, Samsung NeuroLogica launched an upgraded version of its previous BodyTom 32-slice CT scanner. The new upgraded version features new visual design, upgraded software, hardware, and workstation. Hence, key players in the market are focused on developing and updating their neurological diagnostic devices with latest technologies and are launching them in market, in order to increase their presence with advanced portfolio and to gain competitive advantage by providing products with latest technologies. Launches of such advanced neurological disorder diagnostics products is expected to aid in growth of the global neurological disorder diagnostics market over the forecast period.
Browse 40 Market Data Tables and 42 Figures spread through 231 Pages and in-depth TOC on Neurological Disorder Diagnostics Market by Technology (Imaging, and In Vitro Diagnostics), by Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026
To know the latest trends and insights prevalent in the Neurological Disorder Diagnostics Market, click the link below:
Key players in the market are focusing on rapid research and development activities, in order to launch diagnostic tools integrated with artificial intelligence. This is expected to aid in gaining share in the market and also create a lucrative opportunity for other key players to focus on and provide advance diagnostic tools. For instance, in 2017, Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. collaborated with MedyMatch Technology, Ltd. to integrate artificial intelligence (AI) clinical decision support technology developed by MedyMatch Technology in its computed tomography (CT) and other imaging equipment. Increasing approval for novel neurological disorder diagnostic products is also expected to fuel growth of the global neurological disorder diagnosis market. For instance, in April 2018, Canon Medical Systems received 510 (k) clearance from the U.S. Food and Drug Administration for its new Aquilion Precision (CT) scanner. Aquilion Precision is an Ultra-High Resolution CT system (UHR CT).
Increasing collaborations among various research institutes for development of novel diagnosis techniques for neurological disorders is expected to drive growth of neurological disorder diagnostics market growth in the near future. For instance, in 2017, Singapore-based National Neuroscience Institute and Nanyang Technological University, Singapore (NTU Singapore) collaborated for development of novel and innovative technologies to better diagnose and treat patients with neurological conditions such as Parkinson’s disease and brain injuries.
Key Takeaways of the Neurological Disorder Diagnostics Market:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.